Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Nov;116(6):2771–2777. doi: 10.1111/j.1476-5381.1995.tb17240.x

Cerebrovascular consequences of repeated exposure to NG-nitro-L-arginine methyl ester.

P A Kelly 1, I M Ritchie 1, F M Collins 1
PMCID: PMC1909153  PMID: 8591003

Abstract

1. Acute treatment with the nitric oxide synthase (NOS) inhibitor NG-nitro-L-arginine methyl ester (L-NAME) produces cerebral oligaemia. The effects of repeated exposure to L-NAME upon cerebral blood flow were examined to determine whether the enhanced NOS inhibition reported following chronic treatment might reduce cerebral perfusion to ischaemic levels. 2. Rats were treated with L-NAME (75 mg kg-1, i.p.) once daily for 10 days. Local cerebral blood flow and glucose utilization were measured by [14C]-iodoantipyrine and [14C]-2-deoxyglucose quantitative autoradiography respectively, either 1 h or 15 h after the last injection. A second group of rats was injected (i.p.) only once with L-NAME, either 1 h or 15 h prior to the measurement procedures. 3. Mean arterial blood pressure (MABP) was significantly increased (+35%) 1 h after a single injection of L-NAME. Although the hypertension was reduced 15 h after the injection (+13%), MABP remained significantly higher than control. 4. Local cerebral blood flow was significantly decreased 1 h after a single injection of L-NAME (ranging from -45% to -54%), and remained so even after 15 h (-39% to -48%). At neither time-point was there any change in glucose utilization. 5. At 15 h after the final injection of the chronic L-NAME treatment protocol, MABP was significantly elevated from control (+58%) and was also significantly higher than at 1 h following a single injection (+20%). There was no effect upon the established hypertension when rats treated chronically with L-NAME were challenged with a further injection of the drug and MABP was measured 1 h later, suggesting saturation of NOS inhibition. 6. Although reduced, cerebral blood flow was not significantly different from control when measured 15 h after the last injection of the chronic L-NAME treatment. When rats treated chronically with L-NAME were subjected to a further challenge with the drug, cerebral blood flow was reduced when measured 1 h after the acute injection (ranging from -34% to -41%). There was however evidence of some attenuation in the response when compared to that measured 1 h after a single injection of L-NAME (ranging from -45% to -54%). Thus, the cerebral circulation shows no evidence of either sustained L-NAME-induced vasoconstriction or saturated NOS inhibition following 10 daily injections of L-NAME. Chronic L-NAME treatment had no effect upon cerebral glucose use. 7. The trend towards re-establishment of cerebrovascular dilator tone and the normalization of cerebral flow-metabolism relationships could explain the lack of any ischaemic damage found in chronically treated rats, but the loss of an extended autoregulatory range afforded by acute L-NAME treatment may be responsible for an increased incidence of stroke.

Full text

PDF
2771

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bannerman D. M., Chapman P. F., Kelly P. A., Butcher S. P., Morris R. G. Inhibition of nitric oxide synthase does not impair spatial learning. J Neurosci. 1994 Dec;14(12):7404–7414. doi: 10.1523/JNEUROSCI.14-12-07404.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blot S., Arnal J. F., Xu Y., Gray F., Michel J. B. Spinal cord infarcts during long-term inhibition of nitric oxide synthase in rats. Stroke. 1994 Aug;25(8):1666–1673. doi: 10.1161/01.str.25.8.1666. [DOI] [PubMed] [Google Scholar]
  3. Bryant C. E., Allcock G. H., Warner T. D. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses. Br J Pharmacol. 1995 Apr;114(8):1673–1679. doi: 10.1111/j.1476-5381.1995.tb14956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dirnagl U., Lindauer U., Villringer A. Role of nitric oxide in the coupling of cerebral blood flow to neuronal activation in rats. Neurosci Lett. 1993 Jan 4;149(1):43–46. doi: 10.1016/0304-3940(93)90343-j. [DOI] [PubMed] [Google Scholar]
  5. Dwyer M. A., Bredt D. S., Snyder S. H. Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo. Biochem Biophys Res Commun. 1991 May 15;176(3):1136–1141. doi: 10.1016/0006-291x(91)90403-t. [DOI] [PubMed] [Google Scholar]
  6. Gardiner S. M., Compton A. M., Bennett T., Palmer R. M., Moncada S. Regional haemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol. 1990 Sep;101(1):10–12. doi: 10.1111/j.1476-5381.1990.tb12079.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gardiner S. M., Kemp P. A., Bennett T. Effects of chronic treatment with nitric oxide synthase inhibitors on regional haemodynamic responses to vasodilators in conscious Brattleboro rats. Br J Pharmacol. 1993 May;109(1):222–228. doi: 10.1111/j.1476-5381.1993.tb13557.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gardiner S. M., Kemp P. A., Bennett T., Palmer R. M., Moncada S. Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats. Eur J Pharmacol. 1992 Mar 31;213(3):449–451. doi: 10.1016/0014-2999(92)90636-i. [DOI] [PubMed] [Google Scholar]
  9. Gardiner S. M., Kemp P. A., Bennett T. Regional haemodynamics in Brattleboro rats during chronic ingestion of NG-nitro-L-arginine methyl ester. Blood Press. 1993 Sep;2(3):228–232. doi: 10.3109/08037059309077556. [DOI] [PubMed] [Google Scholar]
  10. Goadsby P. J., Kaube H., Hoskin K. L. Nitric oxide synthesis couples cerebral blood flow and metabolism. Brain Res. 1992 Nov 6;595(1):167–170. doi: 10.1016/0006-8993(92)91470-y. [DOI] [PubMed] [Google Scholar]
  11. Iadecola C., Zhang F., Xu X. Role of nitric oxide synthase-containing vascular nerves in cerebrovasodilation elicited from cerebellum. Am J Physiol. 1993 Apr;264(4 Pt 2):R738–R746. doi: 10.1152/ajpregu.1993.264.4.R738. [DOI] [PubMed] [Google Scholar]
  12. Kelly P. A., Thomas C. L., Ritchie I. M., Arbuthnott G. W. Cerebrovascular autoregulation in response to hypertension induced by NG-nitro-L-arginine methyl ester. Neuroscience. 1994 Mar;59(1):13–20. doi: 10.1016/0306-4522(94)90094-9. [DOI] [PubMed] [Google Scholar]
  13. Kovách A. G., Szabó C., Benyó Z., Csáki C., Greenberg J. H., Reivich M. Effects of NG-nitro-L-arginine and L-arginine on regional cerebral blood flow in the cat. J Physiol. 1992 Apr;449:183–196. doi: 10.1113/jphysiol.1992.sp019081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Koźniewska E., Oseka M., Styś T. Effects of endothelium-derived nitric oxide on cerebral circulation during normoxia and hypoxia in the rat. J Cereb Blood Flow Metab. 1992 Mar;12(2):311–317. doi: 10.1038/jcbfm.1992.43. [DOI] [PubMed] [Google Scholar]
  15. MacKenzie E. T., McGeorge A. P., Graham D. I., Fitch W., Edvinsson L., Harper A. M. Effects of increasing arterial pressure on cerebral blood flow in the baboon: influence of the sympathetic nervous system. Pflugers Arch. 1979 Jan 31;378(3):189–195. doi: 10.1007/BF00592735. [DOI] [PubMed] [Google Scholar]
  16. Macrae I. M., Dawson D. A., Norrie J. D., McCulloch J. Inhibition of nitric oxide synthesis: effects on cerebral blood flow and glucose utilisation in the rat. J Cereb Blood Flow Metab. 1993 Nov;13(6):985–992. doi: 10.1038/jcbfm.1993.123. [DOI] [PubMed] [Google Scholar]
  17. McCulloch J., Kelly P. A., Ford I. Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis). J Cereb Blood Flow Metab. 1982 Dec;2(4):487–499. doi: 10.1038/jcbfm.1982.56. [DOI] [PubMed] [Google Scholar]
  18. Morton J. J., Beattie E. C., Speirs A., Gulliver F. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J Hypertens. 1993 Oct;11(10):1083–1088. doi: 10.1097/00004872-199310000-00012. [DOI] [PubMed] [Google Scholar]
  19. Northington F. J., Matherne G. P., Berne R. M. Competitive inhibition of nitric oxide synthase prevents the cortical hyperemia associated with peripheral nerve stimulation. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6649–6652. doi: 10.1073/pnas.89.14.6649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pelligrino D. A., Koenig H. M., Albrecht R. F. Nitric oxide synthesis and regional cerebral blood flow responses to hypercapnia and hypoxia in the rat. J Cereb Blood Flow Metab. 1993 Jan;13(1):80–87. doi: 10.1038/jcbfm.1993.10. [DOI] [PubMed] [Google Scholar]
  21. Prado R., Watson B. D., Kuluz J., Dietrich W. D. Endothelium-derived nitric oxide synthase inhibition. Effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats. Stroke. 1992 Aug;23(8):1118–1124. doi: 10.1161/01.str.23.8.1118. [DOI] [PubMed] [Google Scholar]
  22. Ribeiro M. O., Antunes E., de Nucci G., Lovisolo S. M., Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension. 1992 Sep;20(3):298–303. doi: 10.1161/01.hyp.20.3.298. [DOI] [PubMed] [Google Scholar]
  23. Sakurada O., Kennedy C., Jehle J., Brown J. D., Carbin G. L., Sokoloff L. Measurement of local cerebral blood flow with iodo [14C] antipyrine. Am J Physiol. 1978 Jan;234(1):H59–H66. doi: 10.1152/ajpheart.1978.234.1.H59. [DOI] [PubMed] [Google Scholar]
  24. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M. H., Patlak C. S., Pettigrew K. D., Sakurada O., Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977 May;28(5):897–916. doi: 10.1111/j.1471-4159.1977.tb10649.x. [DOI] [PubMed] [Google Scholar]
  25. Sokoloff L. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. Fed Proc. 1981 Jun;40(8):2311–2316. [PubMed] [Google Scholar]
  26. Talman W. T., Dragon D. N. Inhibition of nitric oxide synthesis extends cerebrovascular autoregulation during hypertension. Brain Res. 1995 Feb 20;672(1-2):48–54. doi: 10.1016/0006-8993(94)01381-q. [DOI] [PubMed] [Google Scholar]
  27. Tanaka K., Gotoh F., Gomi S., Takashima S., Mihara B., Shirai T., Nogawa S., Nagata E. Inhibition of nitric oxide synthesis induces a significant reduction in local cerebral blood flow in the rat. Neurosci Lett. 1991 Jun 10;127(1):129–132. doi: 10.1016/0304-3940(91)90911-c. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES